Amar Abdullah

I completed my PhD in 2018 from Neuropharmacology Lab under the supervision of Professor Peter Crack and Dr Juliet Taylor in the Dept of Pharmacology and Therapeutics, The University of Melbourne.  I currently hold a position as an early career Research Fellow in the Neuropharmacology Lab since the completion of my PhD. My thesis entitled ‘STING-mediated type-I interferons contribute to the neuroinflammatory process and detrimental effects following traumatic brain injury’ has been published in the top-ranked Journal of Neuroinflammation (IF:5.8). In the Neuropharmacology lab, my research project focuses on the mechanisms of cell death seen in neural injury and the effect that neuroinflammation contributes to neural cell death utilizing both animal models and cell culture assays. I have presented my research outcomes at National and International meetings including the International Congress of Immunology and the prestigious Annual Meeting of the Australasian Neuroscience Society for the past 5 years.  In 2019 I was awarded Brain Foundation research gift allowing me to be a lead investigator in screening a novel compound that minimises the effects of neuronal cell death after traumatic brain injury.  I am also one of the lead investigators involved in a research project between CSL and the University of Melbourne in screening for neuroprotective compounds after traumatic brain injury.

  • Contact Details
  • Current Research Focus

    TBI mouse model neurotoxicity assay

    Field of ResearchDescription
    110903Central Nervous System
    111501Basic Pharmacology
  • Key Skills
    • behavioural assays
    • cell culture
    • QPCR histology western blot microscopy
    • TBI model iv ip
  • Looking to collaborate?

    Mitochondria expert , neurotoxicity related